| IGF-1 LR3Muscle protein synthesis, extended half-life IGF-1, anabolic | Growth Hormone | Animal | Not Approved | 102 human |
| GHRP-2Potent GH release, appetite stimulation, body composition | Growth Hormone | Animal | Not Approved | 203132 human |
| SermorelinGrowth hormone stimulation, sleep quality, anti-aging | Growth Hormone | Approved | Not Approved | 2114 human |
| CJC-1295 with DACLong-acting GH elevation, less frequent dosing, sustained IGF-1 increase | Growth Hormone | Phase II | Not Approved | 0 |
| IpamorelinSelective growth hormone release, body composition, sleep quality | Growth Hormone | Phase II | Not Approved | 4419 human |
| MK-677 (Ibutamoren)Oral GH secretagogue, sleep quality, muscle preservation | Growth Hormone | Phase III | Not Approved | 0 |
| HexarelinMost potent GHRP, cardioprotective effects, GH secretion research | Growth Hormone | Animal | Not Approved | 288168 human |
| TrevogrumabMyostatin blocker, anti-muscle-loss for GLP-1 users, Regeneron antibody | Growth Hormone | Phase II | Investigational | 22 human |
| Follistatin-344Myostatin inhibition, muscle growth, muscular dystrophy research | Growth Hormone | Phase I | Not Approved | 43 human |
| TesamorelinVisceral fat reduction, growth hormone deficiency, lipodystrophy | Growth Hormone | Approved | Approved | 8568 human |
| HGHGrowth hormone deficiency, anti-aging, body composition | Growth Hormone | Approved | Approved | 46813670 human |
| CJC-1295/IpamorelinGrowth hormone release, body composition, anti-aging | Growth Hormone | Phase II | Not Approved | 0 |
| GHRP-6Growth hormone release, appetite stimulation, gut motility | Growth Hormone | Animal | Not Approved | 632234 human |